The possibility of development of hypomagnesemia of surgical patients

Abstract


The modern diagnostic and correction of disorders of water-electrolytic balance plays a most important role on stages of treatment of surgical patients. Many patients are accepted into hospital already with expressed disorders of content of such cations as potassium, sodium, calcium. Especially is expected outbalance of electrolytes in patients with acute abdominal pathology - peritonitis, intestinal obstruction, acute pancreatitis, etc. At the same time, disorders of water-electrolytic balance in surgical patients can be conditioned not only by main surgical pathology. One is to consider presence of number of concomitant diseases of cardio-vascular system, kidneys, endocrine glands, gastrointestinal tract and also prolonged intake of various groups of medications. The article analyzes various aspects of development of hypomagnesemia during perioperational period in surgical patients. The importance of dynamic control of level of Magnesium (Mg2+) in blood plasma is established.

Full Text

Restricted Access

About the authors

S. V Sviridov

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

Email: sergey.sviridov.59@mail.ru
117997, Moscow, Russian Federation

I. V Vedenina

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

117997, Moscow, Russian Federation

V. G Kochergin

The N.I. Pirogov Russian national research medical university Minzdrav of Russia

117997, Moscow, Russian Federation

References

  1. Шаповальянц С.Г., Ларичев С.Е., Жемухова З.А., Солдатова Н.А., Смирнов И.А. Прогнозирование эффективности консервативной терапии при острой спаечной тонкокишечной непроходимости. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2011; (1): 57-62.
  2. Былова Н.А. Калия и магния аспарагинат в практике терапевта. Трудный пациент. 2013; (1): 21-4.
  3. Трисветова Е.Л. Магний в клинической практике. Рациональная фармакотерапия в фармакологии. 2012; 8(4): 545-53.
  4. Chakraborty P.K., Hoque M.R., Paul U.K., Husain F. Serum magnesium status among acute myocardial infarction patients in Bangladesh. Mymensingh Med J. 2014; 23(1): 41-45.
  5. Vassalle C., Battaglia D., Vannucci A., Chatzianagnostou K., Landi P., Arvia C. et al. Low magnesium is not a significant predictor of hard events in acute myocardial infarction. BBA Clin. 2016; (5): 130-3.
  6. Чуканова Е.И. Применение магния (Магнерот) в лечении сосудистых заболеваний. Лечащий врач. 2008; (5-6): 11-6.
  7. Султанова Л.М. Проблемы диагностики и лечения диабетического кетоацидоза у детей и подростков. Вестник современной клинической медицины. 2016; 9(2): 93-7.
  8. Ramadass S., Basu S., Srinivasan A.R. SERUM magnesium levels as an indicator of status of Diabetes Mellitus type 2. Diabetes Metab. Syndr. 2015; 9(1): 42-5
  9. Костюченко Л.Н. Нарушения калий-магниевого гомеостаза и его коррекция в ходе нутриционной поддержки больных гастроэнтерологического профиля. Трудный пациент. 2010; 8(10): 40-7.
  10. Иванова Н.Г., Петрова П.Г., Голубев А.М., Потапов А.Ф. Оценка нарушений гемодинамики и водного баланса у беременных с гестозом во время операции кесарево сечение. Якутский медицинский журнал. 2013; (4): 16-9.
  11. Yang S.J., Hwang S.Y., Baik S.H., Lee K.W., Nam M.S., Park Y.S. et al. Serum magnesium level is associated with type 2 diabetes in women with a history of gestational diabetes mellitus: the Korea National Diabetes Program study. J. Korean Med. Sci. 2014; 29(1): 84-9.
  12. Lameris A.L., Monnens L.A., Bindels R.J., Hoenderop J.G. Drug-induced alterations in Mg2+ homoeostasis. Clin. Sci (Lond). 2012; 123(1): 1-14.
  13. Hansen B.A., Bruserud Ø. Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole. Oxf. Med. Case Reports. 2016; 2016(7): 147-9.
  14. Dimke H., Monnens L., Hoenderop J.G., Bindels R.J. Evaluation of hypomagnesemia: lessons from disorders of tubular transport. Am. J. Kidney Dis. 2013; 62(2): 377-83.
  15. Lee J.W. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press. 2010; 8(2): 72-81.
  16. Gunnerson K.J. Clinical review: The meaning of acid-base abnormalities in the intensive care unit part I - epidemiology. Crit. Care. 2005; 9(5): 508-16.
  17. Wartak S.A., Mehendale R.A., Freda B., Verma A., Rose D.N. Altered mental status and low anion gap in a patient with sickle cell anemia: a case report. J. Med. Case Rep. 2012; (6): 72.
  18. Streb J., Püsküllüoğlu M., Glanowska I., Ochenduszko S., Konopka K., Łupkowski R. et al. Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature. Oncol. Lett. 2015; 10(6): 3749-55.
  19. Rayssiguier Y., Libako P., Nowacki W., Rock E. Magnesium deficiency and metabolic syndrome: stress and inflammation may reflect calcium activation. Magnes. Res. 2010; 23(2): 73-80.
  20. Nielsen F.H. Magnesium, inflammation, and obesity in chronic disease. Nutr. Rev. 2010; 68(6): 333-40.
  21. Morais J.B., Severo J.S., Santos L.R., de Sousa Melo S.R., de Oliveira Santos R., de Oliveira A.R. et al. Author information Role of Magnesium in Oxidative Stress in Individuals with Obesity. Biol. Trace Elem. Res. 2016; 176(1): 20-6.
  22. Торшин И.Ю., Громова О.А. Дисплазия соединительной ткани, клеточная биология и молекулярные механизмы воздействия магния. РМЖ. 2008; 16(4): 230-8
  23. González E.P., Santos F., Coto E. Magnesium homeostasis. Etiopathogeny, clinical diagnosis and treatment of hypomagnesaemia. A case study. Nefrologia, 2009; 29(6): 518-24. (in Spanish)
  24. Pham P.C., Pham P.A., Pham S.V., Pham P.T., Pham P.M, Pham P.T. Hypomagnesemia: a clinical perspective. Int. J. Nephrol. Renovasc. Dis. 2014; 7: 219-30.
  25. Denny J.T., Pantin E., Chiricolo A., Tse J., Jan T., Chaudhry M. et al. Lower incidence of hypo-magnesemia in surgical intensive care unit patients in 2011 versus 2001. J. Clin. Med. Res. 2015; 7(4): 253-6.
  26. Gröber U., Schmidt J., Kisters K. Magnesium in Prevention and Therapy. Nutrients. 2015; 7(9): 8199-226.
  27. Kumar S., Honmode A., Jain S., Bhagat V. Does magnesium matter in patients of Medical Intensive Care Unit: A study in rural Central India. Indian J. Crit. Care Med. 2015; 19(7): 379-83.
  28. Djagbletey R., Boni F., Phillips B., Adu-Gyamfi Y., Aniteye E., Owoo C. et al. Prevalence and predictive factors of preoperative hypomagnesaemia among adult surgical patients in a large tertiary hospital in Ghana. BMC Anesthesiol. 2015; 15: 132.
  29. Velissaris D., Karamouzos V., Pierrakos C., Aretha D., Karanikolas M. Hypomagnesemia in Critically Ill Sepsis Patients. J. Clin. Med. Res. 2015; 7(12): 911-8.
  30. Гапонова Н.И., Абдрахманов В.Р., Кадышев В.А., Соколов А.Ю. Нарушения калий-магниевого гомеостаза в клинической практике: коррекция сбалансированным раствором калия и магния аспарагината. Лечащий врач. 2014; (2): 27-32
  31. Kiberd B.A., Tennankore K.K., Daley C.J. Increases in intravenous magnesium use among hospitalized patients: an institution cross-sectional experience. Can. J. Kidney Health Dis. 2015; 2: 24.
  32. Ayuk J., Gittoes N.J. How should hypomagnesaemia be investigated and treated? Clin. Endocrinol. (Oxf). 2011; 75(6): 743-6.
  33. Zafar M.S., Wani J.I., Karim R., Mir M.M., Koul P.A. Significance of serum magnesium levels in critically ill-patients. Int. J. Appl. Basic Med. Res. 2014; 4(1): 34-7.
  34. Fairley J., Glassford N.J., Zhang L., Bellomo R. Magnesium status and magnesium therapy in critically ill patients: A systematic review. J. Crit. Care. 2015; 30(6): 1349-58.
  35. Safavi M., Honarmand A. Admission hypomagnesemia-impact on mortality or morbidity in critically ill patients. Middle East. J. Anaesthesiol. 2007; 19(3): 645-60.
  36. Haider D.G., Lindner G., Ahmad S.S., Sauter T., Wolzt M., Leichtle A.B. et al. Hypermagnesemia is a strong independent risk factor for mortality in critically ill patients: Results from a cross-sectional study. Eur. J. Intern. Med. 2015; 26(7): 504-7.
  37. Chen M., Sun R., Hu B. The influence of serum magnesium level on the prognosis of critically ill patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015; 27(3): 213-7. (in Chinese)
  38. Upala S., Jaruvongvanich V., Wijarnpreecha K., Sanguankeo A. Hypomagnesemia and mortality in patients admitted to intensive care unit: a мsystematic review and meta-analysis. QJM. 2016; 109(7): 453-9.
  39. Ho K.M., Leonard A. Risk factors and outcome associated with hypomagnesemia in massive transfusion. Transfusion. 2011; 51(2): 270-6.
  40. Florentin M., Elisaf M.S. Proton pump inhibitor-induced hypomagnesemia: A new challenge. World J. Nephrol. 2012; 1(6): 151-4.
  41. García F.B., Sanchez I., Arrieta F., Calañas A., Botella-Carretero J.I., Zamarron I. et al. Short bowel syndrome cause of hypomagnesaemia importance of its diagnosis and treatment. Nutr. Hosp. 2014; 29(2): 456-9. (in Spanish)
  42. Braga C.B., Ferreira I.M., Marchini J.S., Cunha SF. Copper and magnesium deficiencies in patients with short bowel syndrome receiving parenteral nutrition or oral feeding. Arq. Gastroenterol. 2015; 52(2): 94-9.
  43. Scherkenbach L.A., Kraft M.D., Stout S.M., Dorsch M.P., Chen X., Tran H.D. et al. Impact of an Intravenous Magnesium Shortage on Potassium Doses in Adult Surgical Patients Receiving Parenteral Nutrition. JPEN.J. Parenter. Enteral. Nutr. 2016; 40(5): 688-92.
  44. Miranda S.C., Ribeiro M.L., Ferriolli E., Marchini J.S. Hypomagnesemia in short bowel syndrome patients. Sao Paulo Med. J. 2000; 118(6): 169-7.
  45. Ahmed A., Azim A., Gurjar M., Baronia A.K. Hypocalcemia in acute pancreatitis revisited. Indian J. Crit. Care Med. 2016; 20(3): 173-7.
  46. Dias C., Carreira L.M. Serum ionised calcium as a prognostic risk factor in the clinical course of pancreatitis in cats. J. Feline Med. Surg. 2015; 17(12): 984-90.
  47. Huang L., Ma B., He F., Yang S. Electrocardiographic, cardiac enzymes, and magnesium in patients with severe acute pancreatitis. Gastroenterol. Nurs. 2012; 35(4): 256-60.
  48. Shen F., Cai W.S., Li J.L., Feng Z., Cao J., Xu B. The Association Between Serum Levels of Selenium, Copper, and Magnesium with Thyroid Cancer: a Meta-analysis. Biol. Trace Elem. Res. 2015; 167(2): 225-35.
  49. Moulin S.R., Mill J.G., Rosa W.C., Hermisdorf S.R., Caldeira Lda C., Zago-Gomes E.M. QT interval prolongation associated with low magnesium in chronic alcoholics. Drug. Alcohol Depend. 2015; 155: 195-201.
  50. Рашид М.А., Карпова Н.Ю., Погонченкова И.В., Шостак Н.А., Ядров М.Е., Суряхина Я.И. Магний в клинике внутренних болезней. РМЖ. 2015; 23(28): 1705-9
  51. Assarzadegan F., Asgarzadeh S., Hatamabadi H.R., Shahrami A., Tabatabaey A., Asgarzadeh M. Serum concentration of magnesium as an independent risk factor in migraine attacks: a matched case-control study and review of the literature. Int. Clin. Psychopharmacol. 2016; 31(5): 287-92.
  52. Tamura T., Sakaeda T., Kadoyama K., Okuno Y. Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System. Int. J. Med. Sci. 2012; 9(5): 322-6.
  53. Захарова Н.В. Подводные камни длительной кислотосупрессии ингибиторами протонной помпы. Лечащий врач. 2014; (8): 21-6
  54. Epstein M., McGrath S., Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N. Engl. J. Med. 2006; 355(17): 1834-6.
  55. Hess M.W., Hoenderop J.G., Bindels R.J., Drenth J.P. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment. Pharmacol. Ther. 2012; 36(5): 405-13.
  56. Wang A.K., Sharma S., Kim P., Mrejen-Shakin K. Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature. Indian J.Crit. Care Med. 2014; 18(7): 456-60.
  57. Mikolasevic I., Milic S., Stimac D., Zaputovic L., Lukenda Zanko V., Gulin T. et al. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis? Eur. J. Intern Med. 2016; 30: 99-103.
  58. Ayuk J., Gittoes N.J. Contemporary view of the clinical relevance of magnesium homeostasis. Ann. Clin. Biochem. 2014; 51(Pt. 2): 179-88.
  59. Yi J.H., Han S.W. Is hypomagnesemia associated with using proton pump inhibitors? Kidney Res. Clin. Pract. 2016; 35(2): 128-9.

Statistics

Views

Abstract - 32

PDF (Russian) - 0

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies